These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 552849)

  • 1. [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers].
    Gentile S; Porcellini M; Foglia F; Loguercio C; Coltorti M
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):345-8. PubMed ID: 552849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pyrogen induced fever on pharmacokinetics of rifamycin SV.
    Leszczyńska A
    Pol J Pharmacol Pharm; 1979; 31(1):19-24. PubMed ID: 482163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of detecting organic cholephilic anions in man: comparative studies on plasma depuration of rifamycin-SV. Interference of nicotinic acid and phenobarbital].
    Gentile S; Porcellini M; Foglia F; Coltorti M
    Boll Soc Ital Biol Sper; 1979 Jul; 55(13):1307-11. PubMed ID: 508427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.
    Uchida S; Yamada H; Li XD; Maruyama S; Ohmori Y; Oki T; Watanabe H; Umegaki K; Ohashi K; Yamada S
    J Clin Pharmacol; 2006 Nov; 46(11):1290-8. PubMed ID: 17050793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tuberculostatic agents on the response of serum growth hormone and immunoreactive insulin to intravenous tolbutamide, and on the half-life of tolbutamide.
    Syvälahti E; Pihlajamäki K; Iisalo E
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):83-9. PubMed ID: 1254383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolbutamide kinetics in cigarette smokers in the Indian population.
    Uppal R; Sharma PL; Prakash C; Gupta HR
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):82-4. PubMed ID: 3957496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired plasma clearance of nicotinic acid and rifamycin-SV in Gilbert's syndrome: evidence of a functional heterogeneity.
    Gentile S; Marmo R; Persico M; Bronzino P; Coltorti M
    Hepatogastroenterology; 1985 Jun; 32(3):113-6. PubMed ID: 4018705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application].
    Fenner H; Schiemann O; Gikalov I
    Arzneimittelforschung; 1985; 35(7):1093-6. PubMed ID: 4052144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma clearance of nicotinic acid and rifamycin-SV, and their interaction in Gilbert's syndrome: application of a compartmental model.
    Gentile S; Marmo R; Persico M; Bronzino P; Coltorti M
    Hepatogastroenterology; 1984 Apr; 31(2):72-5. PubMed ID: 6724499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uniform elimination pattern for glibenclamide in healthy Caucasian males.
    Spraul M; Streeck A; Nieradzik M; Berger M
    Arzneimittelforschung; 1989 Nov; 39(11):1449-50. PubMed ID: 2515863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half life of intravenous tolbutamide in the serum of patients in medical wards.
    Sotaniemi EA; Huhti E
    Ann Clin Res; 1974 Jun; 6(3):146-54. PubMed ID: 4844125
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of pargyline with tolbutamide in rabbits.
    Satyanarayana S; Krishna DM; Krishnaiah YS; Visweswaram D
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):71-3. PubMed ID: 7705875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of corticosteroid on hexobarbital and tolbutamide disposition.
    Breimer DD; Zilly W; Richter E
    Clin Pharmacol Ther; 1978 Aug; 24(2):208-12. PubMed ID: 679598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolbutamide kinetics in a normal Indian population.
    Uppal R; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):95-6. PubMed ID: 3988400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
    Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I
    Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.
    Yousef AM; Arafat T; Bulatova NR; Al-Zumyli R
    J Clin Pharm Ther; 2008 Aug; 33(4):439-49. PubMed ID: 18613862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between tolbutamide and ketoconazole in healthy subjects.
    Krishnaiah YS; Satyanarayana S; Visweswaram D
    Br J Clin Pharmacol; 1994 Feb; 37(2):205-7. PubMed ID: 8186066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.
    Svendsen TL; Kristensen MB; Hansen JM; Skovsted L
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):439-41. PubMed ID: 971708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
    Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
    Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.